Psychedelics, a class of hallucinogenic drugs with powerful mind-altering capabilities, are having a moment. While some have been used by traditional healers for thousands of years, as a matter of law today they are federally illegal substances considered to have no medical value. But the field is at an inflection point. As clinical research grows, and state and local laws change, the future of psychedelics policy is being shaped by a wide range of interests, including healthcare workers, government regulators, pharmaceutical startups and traditional use advocates. On this episode of Law360 Explores: Psychedelics, we investigate the emerging medical promise, the grassroots decriminalization movement and the activists focused on fair access and equity, all of which will determine where the industry goes from here.